Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Almac has launched IXRS 2.0 integrated, interactive voice (IVR) and web response (IWR) technology with smart menus and intuitive task management to achieve new levels of productivity at clinical trial sites and sponsor organisations worldwide.
Subscribe to our email newsletter
Almac IXRS 2.0 smart menu technology presents users with valid options and guides them to correct choices, directing their workflow in a logical and intuitive manner.
According to Almac, IXRS 2.0 was designed to facilitate many of the aspects of modern clinical trials. It features increased randomisation functionality and cohort management capabilities for adaptive and other complex trial designs, helping to shorten timelines on such studies.
Additionally, given the growing number of biologics in the development pipeline, IXRS 2.0 offers several new features for cold chain management, temperature excursion tracking, and other vital functions to assure that expensive biologics are closely monitored and are not wasted.
Jim Murphy, president of clinical technologies division at Almac, said: “Almac was the pioneer of integrated phone and web platform technology in our industry when we released IXRS in 2006. Since then, we have added new features and functionalities each year to establish IXRS as the most flexible and efficient platform in the market. With IXRS 2.0, Almac takes IVR/IWR technology to a new level.
“Since over 50% of IXRS transactions are now conducted online, we have added smart menus and informed navigation, along with other key features to greatly improve the user experience and improve the quality of data we collect for biopharmaceutical clients.”
Valarie Higgins, vice president of Almac clinical project services, said: “Our clients are facing tremendous pressures to streamline clinical trials, improve sponsor and site productivity, and reduce timelines. IXRS 2.0 was designed to achieve all three of those goals. We spent considerable time interviewing sponsors to assure we delivered on their most pressing needs with IXRS 2.0.
“Combined with the recent release of Almac Interactive Reporting, IXRS 2.0 is revolutionizing the way patients and drug supply are managed in clinical trials.”